# Liquidia

**Canonical:** https://apis.io/providers/liquidia/  
**Website:** https://www.liquidia.com/  
**APIs profiled:** 0

Liquidia Corporation (NASDAQ: LQDA) is a biopharmaceutical company focused on the development and commercialization of inhaled therapies for cardiopulmonary disease, specifically pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Its proprietary PRINT technology produces drug particles of uniform size and shape engineered for deep-lung deposition, and underpins YUTREPIA, its inhaled treprostinil dry powder product. Liquidia is also developing L606, a sustained-release liposomal treprostinil inhalation suspension partnered with Pharmosa Biopharm. Liquidia publishes no public developer portal, API, or machine-readable interface; this profile is catalogued for network identity, corporate transparency, and domain-security coverage only.

## Kin Score — 7.4 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 7.4).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Liquidia Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biopharmaceutical, Pharmaceuticals, Life Sciences, Healthcare, Drug Delivery, Pulmonary Hypertension, Clinical Trials, Inhaled Therapeutics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/liquidia/). Scores are computed from the provider's own public artifacts under a published rubric.